ZA200606070B - Substituted quinolines and their use as mycrobacterial inhibitors - Google Patents

Substituted quinolines and their use as mycrobacterial inhibitors

Info

Publication number: ZA200606070B
Authority: ZA; South Africa
Prior art keywords: mycrobacterial; inhibitors; substituted quinolines; quinolines; substituted
Prior art date: 2004-01-23

Application number

ZA200606070A

Other languages

English (en)

Inventor

Jerome Emile Georges Guillemont

Elisabeth Therese Jeanne Pasquier

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-23

Filing date

2006-07-21

Publication date

2007-12-27

2006-07-21 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2007-12-27 Publication of ZA200606070B publication Critical patent/ZA200606070B/xx

Links

229940111121 antirheumatic drug quinolines Drugs 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
150000003248 quinolines Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

ZA200606070A 2004-01-23 2006-07-21 Substituted quinolines and their use as mycrobacterial inhibitors ZA200606070B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US53876804P	2004-01-23	2004-01-23

Publications (1)

Publication Number	Publication Date
ZA200606070B true ZA200606070B (en)	2007-12-27

Family

ID=34807224

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200606070A ZA200606070B (en)	2004-01-23	2006-07-21	Substituted quinolines and their use as mycrobacterial inhibitors

Country Status (19)

Country	Link
US (1)	US7338949B2 (de)
EP (1)	EP1711492B1 (de)
JP (1)	JP4773975B2 (de)
KR (1)	KR101150172B1 (de)
CN (1)	CN1910177B (de)
AP (1)	AP2188A (de)
AT (1)	ATE392423T1 (de)
AU (1)	AU2005206330B2 (de)
BR (1)	BRPI0507076B8 (de)
CA (1)	CA2553266C (de)
DE (1)	DE602005006101T2 (de)
EA (1)	EA011359B1 (de)
ES (1)	ES2306082T3 (de)
IL (1)	IL177013A0 (de)
NO (1)	NO337705B1 (de)
NZ (1)	NZ547277A (de)
UA (1)	UA85570C2 (de)
WO (1)	WO2005070924A1 (de)
ZA (1)	ZA200606070B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA83875C2 (ru) *	2004-01-29	2008-08-26	Янссен Фармацевтика Н.В.	Производные хинолина для применения в качестве микобактериальных ингибиторов
CA2528849C (en) *	2005-06-08	2014-01-14	Janssen Pharmaceutica N.V.	Quinoline derivatives as antibacterial agents
JO2837B1 (en) *	2005-08-03	2014-09-15	جانسن فارمسيتكا ان في	Quinoline derivatives acting as antibacterial agents
JO2855B1 (en)	2005-08-03	2015-03-15	شركة جانسين فارماسوتيكا ان. في	Quinoline derivatives acting as antibacterial agents
EP1917245A1 (de)	2005-08-21	2008-05-07	Abbott GmbH & Co. KG	Heterocyclische verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
JO3271B1 (ar)	2006-12-06	2018-09-16	Janssen Pharmaceutica Nv	مشتقات الكوينولين المضادة للجراثيم
JO2684B1 (en) *	2006-12-06	2013-03-03	جانسين فارماسوتيكا ان في	Quinoline antibacterial derivatives
JO2685B1 (en)	2006-12-06	2013-03-03	جانسين فارماسوتيكا ان في	Quinoline antibacterial derivatives
JO2970B1 (en)	2006-12-06	2016-03-15	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
US20110059948A1 (en) *	2008-01-14	2011-03-10	Jyoti Chattopadhyaya	Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents
AU2013254670B2 (en) *	2012-04-27	2017-03-30	Janssen Pharmaceutica Nv	Antibacterial quinoline derivatives
ES2576491T3 (es) *	2012-04-27	2016-07-07	Janssen Pharmaceutica, N.V.	Derivados de quinolina antibacterianos
CN108347945B (zh) *	2015-04-29	2021-03-23	以色列农业和农村发展部农业研究组织(范卡尼中心)	抗植物致病组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5965572A (en) *	1996-10-28	1999-10-12	The United States Of America As Respresented By The Secretary Of The Army	Methods for treating antibiotic-resistant infections
IL133212A (en) *	1997-06-02	2005-12-18	Janssen Pharmaceutica Nv	History of use (imidazolil-5-yl) methyl-2-quinolinone that act as culture inhibitors of smooth muscle cells
AU757059B2 (en) *	1997-06-19	2003-01-30	Sepracor, Inc.	Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en)	1997-06-19	2000-08-15	Sepracor, Inc.	Quinoline-indole antimicrobial agents, uses and compositions related thereto
JP2003523381A (ja) *	2000-02-24	2003-08-05	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	投与レジメン
CN1703403A (zh) *	2000-10-02	2005-11-30	詹森药业有限公司	趋代谢的谷氨酸盐受体拮抗剂
SI1527050T1 (sl) *	2002-07-25	2010-08-31	Janssen Pharmaceutica Nv	Kinolinski derivati in njihova uporaba kot mikobakterijski inhibitorji

2005
- 2005-01-21 BR BRPI0507076A patent/BRPI0507076B8/pt not_active IP Right Cessation
- 2005-01-21 WO PCT/EP2005/050267 patent/WO2005070924A1/en not_active Ceased
- 2005-01-21 US US10/596,386 patent/US7338949B2/en not_active Expired - Lifetime
- 2005-01-21 CN CN2005800026797A patent/CN1910177B/zh not_active Expired - Fee Related
- 2005-01-21 ES ES05701586T patent/ES2306082T3/es not_active Expired - Lifetime
- 2005-01-21 NZ NZ547277A patent/NZ547277A/xx not_active IP Right Cessation
- 2005-01-21 CA CA2553266A patent/CA2553266C/en not_active Expired - Fee Related
- 2005-01-21 EP EP05701586A patent/EP1711492B1/de not_active Expired - Lifetime
- 2005-01-21 UA UAA200605780A patent/UA85570C2/uk unknown
- 2005-01-21 EA EA200601363A patent/EA011359B1/ru not_active IP Right Cessation
- 2005-01-21 DE DE602005006101T patent/DE602005006101T2/de not_active Expired - Lifetime
- 2005-01-21 AP AP2006003693A patent/AP2188A/xx active
- 2005-01-21 JP JP2006550174A patent/JP4773975B2/ja not_active Expired - Fee Related
- 2005-01-21 AT AT05701586T patent/ATE392423T1/de active
- 2005-01-21 AU AU2005206330A patent/AU2005206330B2/en not_active Ceased
- 2005-01-21 KR KR1020067013237A patent/KR101150172B1/ko not_active Expired - Fee Related
2006
- 2006-07-20 IL IL177013A patent/IL177013A0/en active IP Right Grant
- 2006-07-21 ZA ZA200606070A patent/ZA200606070B/xx unknown
- 2006-08-22 NO NO20063747A patent/NO337705B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL177013A0 (en)	2006-12-10
HK1100927A1 (zh)	2007-10-05
DE602005006101T2 (de)	2009-07-02
AP2188A (en)	2010-12-14
EA011359B1 (ru)	2009-02-27
NO20063747L (no)	2006-08-22
CA2553266A1 (en)	2005-08-04
CN1910177B (zh)	2010-05-05
NZ547277A (en)	2009-08-28
EA200601363A1 (ru)	2006-12-29
JP4773975B2 (ja)	2011-09-14
AU2005206330B2 (en)	2010-09-16
US20070082895A1 (en)	2007-04-12
BRPI0507076B8 (pt)	2021-05-25
KR20060127016A (ko)	2006-12-11
WO2005070924A8 (en)	2006-05-11
US7338949B2 (en)	2008-03-04
EP1711492A1 (de)	2006-10-18
BRPI0507076B1 (pt)	2019-06-25
ATE392423T1 (de)	2008-05-15
UA85570C2 (uk)	2009-02-10
KR101150172B1 (ko)	2012-05-25
AP2006003693A0 (en)	2006-08-31
DE602005006101D1 (de)	2008-05-29
EP1711492B1 (de)	2008-04-16
BRPI0507076A (pt)	2007-06-19
NO337705B1 (no)	2016-06-06
AU2005206330A1 (en)	2005-08-04
CA2553266C (en)	2013-03-12
JP2007518775A (ja)	2007-07-12
WO2005070924A1 (en)	2005-08-04
CN1910177A (zh)	2007-02-07
ES2306082T3 (es)	2008-11-01

Publication	Publication Date	Title
AP2006003694A0 (en)	2006-08-31	Quinoline derivatives and use thereof as mycobacterial inhibitors
EG25993A (en)	2012-11-28	Heteroaromatic quinoline compounds and their use as pde10 inhibitors
EP1742627A4 (de)	2009-08-26	Pde4b-hemmer und ihre verwendung
ZA200500680B (en)	2006-08-30	Quinoline derivatives and their use as mycrobacterial inhibitors
ZA200701635B (en)	2008-11-26	Quinazolinone derivatives and their use as B-Raf inhibitors
IL190055A0 (en)	2008-08-07	Quinolines and their therapeutic use
ZA200701820B (en)	2008-08-27	Substituted phenylaminothiazoles and use thereof
ZA200701366B (en)	2008-09-25	Quinazolinone derivatives and their use as B-Raf inhibitors
SI1797042T1 (sl)	2009-04-30	Indozolonski derivati kot inhibitorji 11b-hsd1
PL2589599T4 (pl)	2015-06-30	Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4
AP2006003693A0 (en)	2006-08-31	Substituted quinolines and their use as mycobacterial inhibitors
IL176772A0 (en)	2006-10-31	Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
PL380189A3 (pl)	2007-01-08	Azolidynokarbonitryle i ich zastosowanie jako inhibitory DPP-IV
PL2215908T3 (pl)	2012-03-30	2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów
EP1810976A4 (de)	2007-10-17	Benzonaphthacenglykosidderivat und dessen verwendung
ZA200802683B (en)	2009-09-30	Quinolines and their therapeutic use
IL177271A0 (en)	2008-04-13	Heparanase inhibitors and uses thereof
ZA200606671B (en)	2008-02-27	Novel thio-containing hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
GB0402903D0 (en)	2004-03-17	Compounds and their use
GB0401243D0 (en)	2004-02-25	Compounds and their use
GB0401244D0 (en)	2004-02-25	Compounds and their use